193 related articles for article (PubMed ID: 14508108)
1. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
[TBL] [Abstract][Full Text] [Related]
2. The thousand doors that lead to death: p53-dependent repression and apoptosis.
Murphy ME
Cancer Biol Ther; 2003; 2(4):381-2. PubMed ID: 14508109
[No Abstract] [Full Text] [Related]
3. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.
Klokov D; Criswell T; Leskov KS; Araki S; Mayo L; Boothman DA
Mutat Res; 2004 Dec; 568(1):97-110. PubMed ID: 15530543
[TBL] [Abstract][Full Text] [Related]
4. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
[TBL] [Abstract][Full Text] [Related]
5. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
6. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
Wang Y; Wang X; Zhao H; Liang B; Du Q
J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
[TBL] [Abstract][Full Text] [Related]
7. ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.
Goetz EM; Shankar B; Zou Y; Morales JC; Luo X; Araki S; Bachoo R; Mayo LD; Boothman DA
Oncogene; 2011 Sep; 30(35):3745-54. PubMed ID: 21460853
[TBL] [Abstract][Full Text] [Related]
8. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
10. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
[TBL] [Abstract][Full Text] [Related]
12. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
13. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.
Yang CR; Leskov K; Hosley-Eberlein K; Criswell T; Pink JJ; Kinsella TJ; Boothman DA
Proc Natl Acad Sci U S A; 2000 May; 97(11):5907-12. PubMed ID: 10823943
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells.
Huang H; Huang SY; Chen TT; Chen JC; Chiou CL; Huang TM
J Cell Biochem; 2004 Mar; 91(4):756-65. PubMed ID: 14991767
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
Cistulli CA; Kaufmann WK
Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844
[TBL] [Abstract][Full Text] [Related]
16. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
[TBL] [Abstract][Full Text] [Related]
17. Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab.
Biroccio A; D'Angelo C; Jansen B; Gleave ME; Zupi G
J Cell Physiol; 2005 Aug; 204(2):463-9. PubMed ID: 15685647
[TBL] [Abstract][Full Text] [Related]
18. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
Park J; Park SY; Shin E; Lee SH; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kim H; Choi WS
Mol Cells; 2014 Feb; 37(2):178-86. PubMed ID: 24599003
[TBL] [Abstract][Full Text] [Related]
20. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
Kadam R; Harish M; Dalvi K; Teni T
Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]